| 股票代码 | 300347 | 当期评分 | ||||
| 股票名称 | 泰格医药 | |||||
| 报告日期 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | 1.0441 | 0.7038 | 0.5925 | 0.5925 | 0.5925 | ✘ |
| 销售净利润率(%) | 22.0283 | 34.7918 | 60.9869 | 60.9869 | 60.9869 | ✔ |
| 销售毛利率(%) | 42.7034 | 46.0848 | 48.1452 | 48.1452 | 48.1452 | ✔ |
| 净资产收益率(%) | 17.69 | 19.92 | 8.24 | 8.24 | 8.24 | ✘ |
| 营业增长率(%) | 36.3731 | 21.8481 | 13.2678 | 13.2678 | 13.2678 | ✘ |
| 净利润增长率(%) | 52.5702 | 92.4483 | 143.0727 | 143.0727 | 143.0727 | ✔ |
| 每股收益(%) | 0.944 | 1.13 | 1.7139 | 1.3444 | 0.3402 | ✔ |
| 现金流量比率(%) | 43.209 | 29.4611 | 57.4734 | 10.1118 | 4.6216 | ✔ |
| 三项费用比重(%) | 16.3451 | 15.7055 | 20.9229 | 15.8516 | 16.2832 | ✔ |
| 每股净资产(¥) | 5.3353 | 5.6376 | 18.3254 | 6.9193 | 6.0306 | ✔ |
| 流动比率(%) | 1.3265 | 1.8819 | 13.912 | 1.7605 | 1.8195 | ✔ |
| 速动比率(%) | 1.3261 | 1.8813 | 13.9103 | 1.7599 | 1.8182 | ✔ |
| 现金比率(%) | 58.2875 | 114.0512 | 1219.0493 | 103.7097 | 103.7097 | ✔ |
| 总资产利润率(%) | 12.8908 | 16.5135 | 10.6439 | 12.3324 | 3.2879 | ✔ |
| 主营利润比重% | 162.1029 | 118.6142 | 71.6759 | 61.9815 | 104.5959 | ✔ |
| 应收账款(万元) | 78,093.87 | 107,472.22 | 42,155.02 | 41,277.85 | 37,600.41 | ✔ |
| 应收票据(万元) | 73.42 | 567.02 | 503.33 | 372.76 | 496.73 | ✔ |
| 预付款项(万元) | 4,715.77 | 2,607.96 | 4,625.09 | 3,511.40 | 3,767.96 | ✔ |
| 存货(万元) | 51.89 | 120.56 | 155.27 | 129.64 | 241.25 | ✘ |
| 在建工程(万元) | -- | 2,230.91 | 1,342.63 | 1,326.47 | 2,454.93 | ✘ |
| 应付款项(万元) | 4,402.75 | 7,519.15 | 6,140.51 | 6,038.85 | 6,298.58 | ✘ |
| 长期借款(万元) | 343.17 | 3,650.00 | -- | 13,610.00 | 13,610.00 | ✔ |
| 未分配利润(万元) | 101,070.23 | 179,596.43 | 287,420.95 | 255,499.53 | 205,093.37 | ✘ |
| 商誉(万元) | 103,292.69 | 115,783.09 | 152,523.58 | 135,468.11 | 136,312.36 | ✔ |
| 流动资产(万元) | 267,654.08 | 416,269.14 | 631,544.98 | 544,281.50 | 474,156.69 | ✔ |
| 流动负债(万元) | 120,864.22 | 179,069.23 | 89,951.71 | 217,250.13 | 192,394.12 | ✔ |
泰格医药300347评分结果 | 66.67分 | 买入/增持 | ||||